Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Reviewing CapsoVision (CV) and Its Rivals

Short interest in CapsoVision shares rose 19.9% in February amid mixed analyst ratings and 21% revenue growth driven by increased CapsoCam Plus sales, MarketBeat reports.

Summary
CapsoVision (NASDAQ:CV – Get Free Report) is one of 28 public companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it weigh in compared to its competitors? We will compare CapsoVision to similar companies based on the strength of its dividends, profitability, institutional ownership, analyst recommendations, risk, earnings and valuation. Institutional and Insider Ownership 19.3% of shares of all “Surgi…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

americanbankingnews.com broke the news in on Friday, March 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal